Literature DB >> 35389173

Evaluation of ocular surface epithelial and stromal thicknesses in psoriasis using anterior segment optical coherence tomography.

Ismail Ersan1, Sevilay Kilic2, Selda Işik2.   

Abstract

PURPOSE: To evaluate the epithelial and stromal thicknesses of conjunctiva and cornea in psoriatic patients with anterior segment optical coherence tomography (AS-OCT),
METHODS: In this cross-sectional study, 61 patients with psoriasis and 42 age-matched, healthy individuals were enrolled. The epithelial and stromal thicknesses of both inferotemporal bulbar conjunctiva and central cornea were measured using AS-OCT.
RESULTS: Both the tear breakup time and Schirmer-1 test values were significantly lower in the psoriasis group compared with the controls (p < 0.05). The epithelial thickness of conjunctiva and cornea did not differ between psoriasis and control groups (p > 0.05). The central corneal stroma was significantly thicker in the psoriasis group (p = 0.04). PASI was positively correlated with the thickness of central cornea stroma (r = 0.442, p = 0.006) in the nail psoriasis group.
CONCLUSIONS: Psoriasis is not associated with altered epithelial thicknesses of the cornea and conjunctiva. It is accompanied by the stromal thickening of the cornea without conjunctival stromal involvement.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Anterior segment optical coherence tomography; Conjunctiva; Cornea; Dry eye; Epithelium; Psoriasis; Systemic inflammation

Year:  2022        PMID: 35389173     DOI: 10.1007/s10792-022-02289-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  24 in total

1.  Conjunctival impression cytology and tear-film changes in patients with psoriasis.

Authors:  A A Karabulut; I S Yalvac; H Vahaboglu; A B Nurozler; S Duman
Journal:  Cornea       Date:  1999-09       Impact factor: 2.651

2.  Ocular surface disease in psoriatic patients in a developing country.

Authors:  Yihui Goh; Zhenli Kwan; Winn Hui Han; Tajunisah Iqbal; Fariz Yahya; Tsung Fei Khang; Sujaya Singh
Journal:  Int Ophthalmol       Date:  2021-03-31       Impact factor: 2.031

3.  Ocular manifestations of psoriasis.

Authors:  Natasha Ferreira Santos da Cruz; Larissa Silva Brandão; Sérgio Ferreira Santos da Cruz; Sérgio Augusto Sequeira da Cruz; Carla Andréa Avelar Pires; Francisca Regina Oliveira Carneiro
Journal:  Arq Bras Oftalmol       Date:  2018-06       Impact factor: 0.872

4.  A comparison of corneal biomechanical properties in patients with psoriasis and healthy subjects.

Authors:  Ugur Celik; Veysel Aykut; Burcu Celik; Mehmet Tas; Serpil Yazgan; Havva Kaldrm; Sevil Karaman Erdur
Journal:  Eye Contact Lens       Date:  2015-03       Impact factor: 2.018

5.  Dry eye and tear film functions in patients with psoriasis.

Authors:  Young Her; Ji Won Lim; Sang Hak Han
Journal:  Jpn J Ophthalmol       Date:  2013-03-23       Impact factor: 2.447

6.  Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis.

Authors:  Nisha S Chandran; Malcolm Greaves; Fei Gao; Laurence Lim; Bob C L Cheng
Journal:  J Dermatol       Date:  2007-12       Impact factor: 4.005

7.  Tear osmolarity and ocular surface parameters in patients with psoriasis.

Authors:  Goktug Demirci; Sevil Karaman Erdur; Rukiye Aydin; Ali Balevi; Mustafa Eliacik; Mustafa Ozsutcu; Oktay Olmuscelik
Journal:  Arq Bras Oftalmol       Date:  2017 Jan-Feb       Impact factor: 0.872

Review 8.  Psoriasis: Comorbidities.

Authors:  Fumikazu Yamazaki
Journal:  J Dermatol       Date:  2021-03-25       Impact factor: 4.005

9.  Evaluation of Corneal Biomechanical Parameters in Psoriasis Patients: A Controlled Study.

Authors:  Noha A Edris; Shaimaa A Arfeen; Rana Mosaad; Ghada A Nassar
Journal:  Clin Ophthalmol       Date:  2020-06-30

10.  Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis.

Authors:  Angelo Ruggiero; Gabriella Fabbrocini; Sara Cacciapuoti; Eleonora Cinelli; Lucia Gallo; Matteo Megna
Journal:  J Clin Med       Date:  2021-03-03       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.